Advertisement

Topics

Latest "Chlorhexidine Partners Network" News Stories

08:50 EDT 22nd September 2018 | BioPortfolio

Here are the most relevant search results for "Chlorhexidine Partners Network" found in our extensive news archives from over 250 global news sources.

More Information about Chlorhexidine Partners Network on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Chlorhexidine Partners Network for you to read. Along with our medical data and news we also list Chlorhexidine Partners Network Clinical Trials, which are updated daily. BioPortfolio also has a large database of Chlorhexidine Partners Network Companies for you to search.

Showing "Chlorhexidine Partners Network" News Articles 1–25 of 8,500+

Saturday 22nd September 2018

Peritonitis Pipeline Review, H1 2018 [Report Updated: 08052018] Prices from USD $2000

Peritonitis Pipeline Review, H1 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peritonitis Pipeline Review, H1 2018, provides an overview of the Peritonitis Gastrointestinal pipeline landscape.Peritonitis is inflammation of the peritoneum. There are two types of peritonitis. Spontaneous bacterial peritonitis SBP is the result of an infection of the...


Changchun High & New Forms $200 Million Biosimilar JV with Alvotech of Iceland

Changchun High & New Technology formed a $200 million China biosimilar JV with Alvotech, an Icelandic biotech. Changchun will fund the JV with $100 million while Alvotech will contribute $10 million plus six drug licenses valued at $90 million. The permits to use these products will last for five years. Alvotech, founded in 2013, is a sister company to Alvogen, a US generic pharma. Alvoge...

Stemgent Inc Strategic SWOT Analysis Review [Report Updated: 08052018] Prices from USD $125

Stemgent Inc Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.This uptotheminute company report will help you to formulate strategies to drive your business by ena...


Friday 21st September 2018

WesternU’s Pumerantz Lecture Examines How Mindfulness Leads to Positive Health Outcomes

Yi-Yuan Tang, PhD, served as the keynote speaker for the 10th annual Dr. Philip Pumerantz Distinguished Lectureship at Western University of Health Sciences Sept. 20, 2018 in Pomona, California. POMONA, Calif. (PRWEB) September 21, 2018 Mindfulness meditation can result in improved brain function, reduced stress and self-healing, according to the keynote speaker for Western University of Health S...

Lisa Capote de MDO Partners es elegida Presidente Regional de la Florida de la Associacion ...

MIAMI, 21 de septiembre de 2018 /PRNewswire-HISPANIC PR WIRE/ -- MDO Partners se enorgullece de anunciar que la abogada de cumplimiento Lisa Capote ha sido Read more...

Decision aids for parents of children with minor head injuries help communicate with physicians

A series of illustrations and charts designed as decision aids for parents of children with minor head injuries helped them communicate with emergency medicine physicians and make informed decisions about their child's care, according to a study that will appear Sept. 21 in JAMA Network Open.

Celsius Network Selected by Fifth Element Fund to Manage Crypto Assets

NEW YORK, Sept. 21, 2018 /PRNewswire/ -- Announced today at the United Nations, Fifth Element is launching its SDG Impact Fund and will be the Read more...

Intuitive selects InTouch Health as partner to develop Internet of Medical Things network

Under the agreement, the two companies will collaborate to deepen Intuitive’s Internet of Medical Things (IoMT) network to connect into thousands of da Vinci surgical systems in medical The post Intuitive selects InTouch Health as partner to develop Internet of Medical Things network appeared first on Compelo Medical Devices.

Beat Richner, Doctor to Cambodia’s Needy Young, Dies at 71

Dr. Richner turned a war-ravaged pediatric hospital in Phnom Penh into a network of five medical centers that now serve one million patients a year.

Covalon Acquires US-based AquaGuard

Under the agreement terms, Covalon will pay over US$12.3 million (C$16.1 million) to AcquaGuard’s business from Cenorin. The company expects the deal to close within 60 days, subject to all regulatory approvals. The post Covalon Acquires US-based AquaGuard appeared first on Investing News Network.

Covalon to Expand US Footprint with AquaGuard Deal

Covalon Technologies announced on Thursday that it will acquire US-based AquaGuard, allowing its product reach in the country to expand. The post Covalon to Expand US Footprint with AquaGuard Deal appeared first on Investing News Network.

Big News Roundup: Kalytera Therapeutics Provides Update for Lead Program in Prevention and Treatment of GVHD; Ascent’s Subsidiary, Agrima Botanicals Corp., Develops Methodology for Water-Soluble Cannabinoid Delivery

In case you missed it, here is this week's big news roundup in the Life Science sector. The post Big News Roundup: Kalytera Therapeutics Provides Update for Lead Program in Prevention and Treatment of GVHD; Ascent’s Subsidiary, Agrima Botanicals Corp., Develops Methodology for Water-Soluble Cannabinoid Delivery appeared first on Investing News Network.

Composition of Terveystalo Plc's Shareholders' Nomination Board

Terveystalo Plc Stock Exchange release 21 September 2018 at 17:30 p.m. EEST   The Shareholders' Nomination Board of Terveystalo Plc comprises the representatives of the four largest shareholders of the company as at 3 September 2018 and, in addition, the Chairman of the Board of Directors. The duties of the Nomination Board include the search, preparation and presentation of ...

Shire Receives Approval of FIRAZYR (icatibant injection) for the Treatment of Hereditary Angioedema (HAE) Attacks in Japan

Shire (LSE:SHP,NASDAQ:SHPG) the leading global biotechnology company focused on rare diseases, announced that the Ministry of Health, Labour and Welfare (MHLW) in Japan has granted manufacturing and marketing authorisation for FIRAZYR (icatibant injection), for the acute treatment of hereditary angioedema (HAE) attacks in adult patients with HAE. As quoted in the press release: HAE is a … C...

Opiant Pharmaceuticals Announces Contract with Biomedical Advanced Research and Development Authority for Up to $4.6 Million to Accelerate Development of OPNT003

Opiant Pharmaceuticals (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions and drug overdose, today announced that it has entered into a multi-year contract with potential funding up to a maximum of approximately $4.6 million, with the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Health and Human Services Office...

Tetraphase Pharmaceuticals Announces Adoption of Commission Decision Granting Marketing Authorisation Approval in the European Union for XERAVA

Tetraphase Pharmaceuticals (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, today announced that the European Commission (EC) has adopted the Decision granting marketing authorisation for XERAVA (eravacycline) for injection for the treatment of complicated intra-abdominal infectio...

Enigma Biomedical and Invicro Sign a Memorandum of Understanding to Co-Develop Synaptic Density Biomarker Imaging

Enigma Biomedical Group (EBG) today announced a collaboration agreement with Invicro, a Konica Minolta Company and a leading provider of imaging services and software for research and drug development, to cooperate in the development of Synaptic Density Biomarker Imaging (“SDI”). SDI promises to provide an important new tool in understanding neurodegen...

Kate Farms Applauds Jerry Brown Signing of SB 1138, a Law Requiring California Institutions to Offer Plant-Based Meals

Kate Farms Plant-based Formulas Meet These New Legal Requirements for Institutional Use, Including Hospitals Kate Farms, Inc., a medical nutrition company leading the next generation of oral and tube feeding formulas commends Jerry Brown on signing SB 1138 into law, ensuring that patients in hospital facilities in California have access to whole...

b-ONE Ortho Receives U.S. FDA 510(k) Clearance for Total Hip System

b-ONE Ortho Corp., an emerging orthopedic technology company dedicated to the development of innovative healthcare solutions, today announced it has received 510(k) clearance for its first device, the b-ONETM Total Hip System, from the U.S. Food and Drug Administration (FDA). The b-ONETM Total Hip System is a cementless total hip system with advan...

BriaCell to Present Clinical and Scientific Data at International Cancer Immunotherapy and The MicroCap Conferences

BriaCell Therapeutics Corp. (TSXV:BCT) (OTCQB: BCTXF) ("BriaCell"), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, announced today it will present the data from biomarker analyses of its clinical trials for advanced breast cancer at the Fourth International Cancer Immunotherapy Conference as well as at The MicroCap Conference, both of which w...

Pipeline Watch: Phase III Readouts For Oral Semaglutide, Roxadustat, Dasiglucagon

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...   

Canon Medical System Corporation partners with ACT Genomics for Precision Cancer Medicine Service in Japan

TAIPEI, Taiwan, Sept. 21, 2018 /PRNewswire/ -- Canon Medical System Corporation (Canon Medical) completed the acquisition of the majority shares of ACTmed - a joint venture company established with ACT Genomics (ACTG), a Taiwanese molecular diagnostic company. ACTG will transfer its clinical NGS technology to ACTmed, making ACTG the first Taiwanese biotech company to transfer technology to a major...

CareStack™ Announces Completion of $16 Million Financing to Expand Cloud-Based Enterprise Platform for Dental Practices

Company Opens New Technology Development Office in the Cambridge Innovation Center CareStack™, a cloud-based technology platform for the dental industry, today announced it has completed $16 million in funding led by Accel, F-Prime Capital Partners, and Eight Roads Ventures. The company will use the ...

UK pharma to work with innovation network on NHS uptake

The five year deal covers AI, genomics, personalised medicine and more

Aliko Dangote Foundation: Africa’s Health Challenges and Investment Opportunities under Spotlight at UN General Assembly

The United Nations Economic Commission for Africa (UNECA), in partnership with GBCHealth and the Aliko Dangote Foundation is bringing together African leaders and other high profile personalities to discuss the continent’s health challenges and opportunities for investment. The partners have organized a meeting themed ‘Africa’s Health and Fi...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks